Bhavnagri Veer 4
4 · Allogene Therapeutics, Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Bhavnagri Veer
General Counsel
Transactions
- Sale
Common Stock
2022-12-15$7.53/sh−5,602$42,186→ 583,677 total
Footnotes (2)
- [F1]1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.